34 Recruiting Studies Using Guselkumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Guselkumab
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
📍 OMI — Buenos Aires,
Arthritis, Psoriatic
View Study & Checklist ➔A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
📍 Children's Hospital Oakland — Oakland, California
Colitis, Ulcerative
View Study & Checklist ➔A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
📍 University of Alabama Liver Center — Birmingham, Alabama
Crohn's Disease
View Study & Checklist ➔A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Valley Gastroenterology Medical Group — Arcadia, California
Colitis, Ulcerative
View Study & Checklist ➔Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
📍 Center for Colitis and Crohns Disease University of California — San Francisco, California
Crohn's Disease
View Study & Checklist ➔A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Research Solutions of Arizona — Litchfield Park, Arizona
Colitis, Ulcerative
View Study & Checklist ➔A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
📍 University of Alabama at Birmingham — Birmingham, Alabama
Fistulizing Crohns Disease
View Study & Checklist ➔A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
📍 Arizona Arthritis and Rheumatology Research PLLC 1 — Avondale, Arizona
Arthritis, Psoriatic
View Study & Checklist ➔A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Om Research LLC — Lancaster, California
Ulcerative Colitis
View Study & Checklist ➔VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
📍 GI Alliance - Sun City — Sun City, Arizona
Crohn's Disease
View Study & Checklist ➔A Study of Guselkumab in Participants With Active Psoriatic Arthritis
📍 Rheumatology Associates — Birmingham, Alabama
Arthritis, Psoriatic
View Study & Checklist ➔A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
Crohn's Disease
View Study & Checklist ➔A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
📍 Stanford University — Palo Alto, California
Psoriasis
View Study & Checklist ➔Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
📍 University of Massachusetts Chan Medical School — Worcester, Massachusetts
Skin Inflammation
View Study & Checklist ➔A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
Crohn Disease
View Study & Checklist ➔Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
📍 Caja Costarricense del Seguro Social — San José, Provincia de San José
Psoriasis
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis
📍 NYU Langone Health — New York, New York
Spondyloarthritis
View Study & Checklist ➔Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
📍 University of California, San Diego — La Jolla, California
Psoriasis
View Study & Checklist ➔A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
Crohn Disease
View Study & Checklist ➔Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
📍 University of California, San Diego — San Diego, California
Psoriatic Arthritis
View Study & Checklist ➔A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
📍 Emory University — Atlanta, Georgia
Crohns Disease
View Study & Checklist ➔Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
📍 Family Arthritis Center — Loxahatchee Groves, Florida
Psoriatic Arthritis
View Study & Checklist ➔Immune Spatial Features of Guselkumab Cutaneous Response
📍 University of California San Francisco — San Francisco, California
Psoriasis of Scalp
View Study & Checklist ➔Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
📍 University of Calgary — Calgary, Alberta
Crohn's Disease of Both Small and Large Intestine
View Study & Checklist ➔Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
📍 Ohio State Dermatology — Columbus, Ohio
Pyoderma Gangrenosum
View Study & Checklist ➔Efficacy of Guselkumab in Treating Hailey Hailey Disease
📍 Church Street Research Unit, Yale Center for Clinical Investigation — New Haven, Connecticut
Hailey Hailey Disease
View Study & Checklist ➔A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
📍 Cedars Sinai Medical Center — Los Angeles, California
Crohn's Disease
View Study & Checklist ➔A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Clinnova Research — Anaheim, California
Colitis, Ulcerative
View Study & Checklist ➔A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
📍 University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
Psoriasis
View Study & Checklist ➔A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
📍 Clinnova Research — Anaheim, California
Crohn Disease
View Study & Checklist ➔Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
📍 University of Calgary — Calgary, Alberta
Inflammatory Bowel Disease (IBD)
View Study & Checklist ➔Multi-Center PAMPA Study
📍 Brigham and Women's Hospital — Boston, Massachusetts
Psoriasis
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔